ANTI-THYROID HORMONE RECEPTOR

All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project <A href="http://www.proteinatlas.org">(www.proteinatlas.org)</A>and as a result, are supported by the most extensive characterization in the industry.

The Human Protein Atlas project can be subdivided into three efforts: Human Tissue Atlas, Cancer Atlas, and Human Cell Atlas. The antibodies that have been generated in support of the Tissue and Cancer Atlas projects have been tested by immunohistochemistry against hundreds of normal and disease tissues and through the recent efforts of the Human Cell Atlas project, many have been characterized by immunofluorescence to map the human proteome not only at the tissue level but now at the subcellular level. These images and the collection of this vast data set can be viewed on the Human Protein Atlas (HPA) site by clicking on the Image Gallery link. To view these <A href="/life-science/cell-biology/antibodies/prestige-antibodies/human-protein-atlas.html#tabs-c509948d-42c4-44c5-b7ea-f12d94c5b4e1">protocols</A> and other useful information about Prestige Antibodies and the HPA, visit <A href="/life-science/cell-biology/antibodies/antibody-products.html?TablePage=20009859">sigma.com/prestige</A>.

Transferrin receptor 1 or TFRC modulates the cellular uptake of iron via endocytosis of transferrin. Hemochromatosis protein HFE competes with transferrin for TFRC binding, and subsequently inhibits the intracellular import of iron. Mutations in HFE eliminate this competition and thereby result in increased cellular uptake of iron by TFRC . Anti-TFRC antibody is specific for TFRC in humans.